MedPath

Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis

Phase 2
Completed
Conditions
Herpes Labialis
Registration Number
NCT00453401
Lead Sponsor
NanoBio Corporation
Brief Summary

Purpose of this study is to determine the safety and efficacy of topical applications of NB-001 as compared to placebo for the treatment of recurrent herpes labialis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • 18 to 80 years of age of either gender
  • Good general health
  • History of recurrent herpes labialis with at least 3 episodes per year
Exclusion Criteria
  • Pregnant and/or nursing female
  • Lesions or irritation on or around the lips that would interfere with recognition of a herpes labialis attack
  • Treatment with topical steroids, antivirals, or new topical products on or around the lips in the week prior to the onset of an attack
  • Known allergies to topical creams, ointments or medications.

Other protocol-defined inclusion/exclusion criteria may apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Time to healing as assessed by the subject.
Secondary Outcome Measures
NameTimeMethod
Percent of subjects with healing by days 3, 4,and 5 as assessed by the subject.

Trial Locations

Locations (28)

Okatie Research Center, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Beaufort, South Carolina, United States

New River Valley Research Institute

๐Ÿ‡บ๐Ÿ‡ธ

Christiansburg, Virginia, United States

Coastal Carolina Research Center

๐Ÿ‡บ๐Ÿ‡ธ

Mt. Pleasant, South Carolina, United States

The Savin Center, PC

๐Ÿ‡บ๐Ÿ‡ธ

New Haven, Connecticut, United States

Westover Heights Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Portland, Oregon, United States

Advanced Clinical Research Institute

๐Ÿ‡บ๐Ÿ‡ธ

Anaheim, California, United States

Advanced Clinical Research, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Boise, Idaho, United States

Medical Affiliated Research Center, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Huntsville, Alabama, United States

Dermatology Treatment & Research Center

๐Ÿ‡บ๐Ÿ‡ธ

Dallas, Texas, United States

Academic Dermatology Associates

๐Ÿ‡บ๐Ÿ‡ธ

Albuquerque, New Mexico, United States

Research Across America

๐Ÿ‡บ๐Ÿ‡ธ

Dallas, Texas, United States

Wake Research Associates, LLM

๐Ÿ‡บ๐Ÿ‡ธ

Raleigh, North Carolina, United States

Clinical Research of West Florida

๐Ÿ‡บ๐Ÿ‡ธ

Clearwater, Florida, United States

DermResearch, PLCC

๐Ÿ‡บ๐Ÿ‡ธ

Louisville, Kentucky, United States

Lederach Family Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Harleysville, Pennsylvania, United States

J&S Studies Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Bryan, Texas, United States

R/D Clinical Research, Inc

๐Ÿ‡บ๐Ÿ‡ธ

Lake Jackson, Texas, United States

Suncoast Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

New Port Richey, Florida, United States

Wenatchee Valley Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Wenatchee, Washington, United States

Benchmark Research

๐Ÿ‡บ๐Ÿ‡ธ

Austin, Texas, United States

South Valley Dermatology Center

๐Ÿ‡บ๐Ÿ‡ธ

West Jordan, Utah, United States

DermResearch Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Austin, Texas, United States

Omega Medical Research

๐Ÿ‡บ๐Ÿ‡ธ

Warwick, Rhode Island, United States

Advanced Healthcare

๐Ÿ‡บ๐Ÿ‡ธ

Milwaukee, Wisconsin, United States

Clinical Physiology Associates

๐Ÿ‡บ๐Ÿ‡ธ

Fort Myers, Florida, United States

Westlake Medical Research

๐Ÿ‡บ๐Ÿ‡ธ

Westlake Village, California, United States

Front Range Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Wheatridge, Colorado, United States

MI Center for Skin Care Research

๐Ÿ‡บ๐Ÿ‡ธ

Clinton Township, Michigan, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath